Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Analyst Breaks Downs Market Action Ahead of Big Tech Earnings
Dory Wiley, president and CEO of Commerce Street Holdings, joined Cheddar News to discuss Tuesday's trading as big tech is set to report earnings. This also followed First Republic Bank posting its latest results that prompted its stock to plummet after it said deposits fell.
Load More